Patents by Inventor Daniel Guay
Daniel Guay has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20230035022Abstract: The present invention relates to a novel gold-based porous material, the use of said gold-based porous material as a precursor of a negative active material, the preparation process of said gold-based porous material, a novel gold-based porous material comprising lithium, the use of said gold-based porous material comprising lithium as a negative electrode material, a lithium-ion battery comprising said gold-based porous material comprising lithium, and a process for the preparation of said gold-based porous material comprising lithium.Type: ApplicationFiled: February 25, 2021Publication date: February 2, 2023Inventors: David Sarinn PECH, Sai-Gourang PATNAIK, Daniel GUAY
-
Publication number: 20210351394Abstract: A method of fabrication of Ni electrodes by hydrogen bubbles dynamic templated electrodeposition of Ni on a substrate, the method comprising one of: i) selecting a current, and selecting an electrodeposition time at the selected current according to a deposit target thickness on the substrate; and ii) selecting an electrodeposition time, and selecting a current during the selected electrodeposition time according to the deposit target thickness on the substrate. The dynamic hydrogen bubble templated Ni films comprises micrometer-sized pores at a surface thereof, and pore walls having a cauliflower-like secondary structure.Type: ApplicationFiled: May 8, 2020Publication date: November 11, 2021Inventors: Daniel GUAY, Julie GAUDET, Minghui HAO, Valerie CHARBONNEAU, Sebastien GARBARINO, Steven J. Thorpe, Pedro Henrique ALVES SOBRINHO
-
Patent number: 10189084Abstract: A method for fabrication of an hydrogen-permeable membrane, comprising forming an alloy of a target composition and structure from powders by mechanically alloying; and forming a membrane from the alloy of the target composition and structure.Type: GrantFiled: October 13, 2016Date of Patent: January 29, 2019Assignee: INSTITUT NATIONAL DE LA RECHERCHE SCIENTIFIQUEInventors: Julie Gaudet, Bruno Manuel Honrado Guerreiro, Jacques Tosques, Lionel Roué, Daniel Guay
-
Publication number: 20180166222Abstract: A method comprising forming a mesoporous conductive layer and depositing a capacitive material within pores of the mesoporous conductive layer through a thickness of the mesoporous conductive layer. The mesoporous conductive layer may be formed by physical deposition or electrodeposition of gold, platinum or titanium, and the capacitive material may be Ru, Ni, Fe, Co, Ir or Mn, yielding a mesoporous electrode. Two such electrodes may be assembled using a solid electrolyte, yielding an all-solid-state supercapacitor. The mesoporous conductive layer may be deposited on a substrate provided with an interdigitated electrode resin mask, and the resin mask removed after depositing the capacitive material within pores of the mesoporous conductive layer, to yield interdigitated electrodes.Type: ApplicationFiled: May 27, 2016Publication date: June 14, 2018Inventors: Anaïs FERRIS, Sébastien GARBARINO, Sarinn David PECH, Daniel GUAY, Jonathan VIENS
-
Patent number: 9745295Abstract: The invention provides certain thiazole-substituted aminoheteroaryl compounds of the Formula (I) or pharmaceutically acceptable salts thereof, wherein X1, X2, X3, X4, Y1, Y2, Y3, Y4, and R4 are as defined herein. The invention also provides pharmaceutical compositions comprising such compounds, and methods of using the compounds for treating diseases or conditions mediated by Spleen Tyrosine Kinase (Syk).Type: GrantFiled: April 22, 2014Date of Patent: August 29, 2017Assignees: Merck Sharp & Dohme Corp., Merck Canada Inc.Inventors: Neville J. Anthony, Brian M. Andresen, Alan B. Northrup, Kaleen K. Childers, Anthony Donofrio, Thomas A. Miller, Yuan Liu, Michelle R. Machacek, Hyun Chong Woo, Kerrie B. Spencer, John Michael Ellis, Michael D. Altman, Eric T. Romeo, Daniel Guay, Jonathan Grimm, Marie-Eve Lebrun, Joel S. Robichaud, Liping Wang, Byron DuBois, Qiaolin Deng
-
Publication number: 20170100773Abstract: A method for fabrication of an hydrogen-permeable membrane, comprising forming an alloy of a target composition and structure from powders by mechanically alloying; and forming a membrane from the alloy of the target composition and structure.Type: ApplicationFiled: October 13, 2016Publication date: April 13, 2017Inventors: JULIE GAUDET, BRUNO MANUEL HONRADO GUERREIRO, JACQUES TOSQUES, LIONEL ROUÉ, DANIEL GUAY
-
Patent number: 9586931Abstract: Provided are triazole derivatives of Formula I which are potent inhibitors of spleen tyrosine kinase and pharmaceutical composition. The triazole derivatives are useful in the treatment and prevention of diseases mediated by said enzyme, such as asthma, COPD, rheumatoid arthritis, and cancer.Type: GrantFiled: September 24, 2013Date of Patent: March 7, 2017Assignees: Merck Sharp & Dohme Corp., Merck Canada Inc.Inventors: Michelle R. Machacek, Eric T. Romeo, Solomon D. Kattar, Matthew Christopher, Michael D. Altman, Alan B. Northrup, John Michael Ellis, Brendan O'Boyle, Anthony Donofrio, Jonathan Grimm, Michael H. Reutershan, Kaleen Konrad Childers, Ryan D. Otte, Brandon Cash, Yves Ducharme, Andrew M. Haidle, Kerrie Spencer, Dilrukshi Vitharana, Lingyun Wu, Li Zhang, Peng Zhang, Christian Beaulieu, Daniel Guay
-
Patent number: 9353066Abstract: The invention provides certain substituted phenyl compounds of the Formula (I) or pharmaceutically acceptable salts thereof, wherein R1, R2, R3, R4, Rcy, and t are as defined herein. The invention also provides pharmaceutical compositions comprising such compounds, and methods of using the compounds for treating diseases or conditions mediated by Spleen Tyrosine Kinase (Syk).Type: GrantFiled: August 15, 2013Date of Patent: May 31, 2016Assignees: Merck Sharp & Dohme Corp., Merck Canada Inc.Inventors: Andrew M. Haidle, Jason Burch, Daniel Guay, Jacques Yves Gauthier, Joel Robichaud, Jean Francois Fournier, John Michael Ellis, Matthew Christopher, Solomon D. Kattar, Graham F. Smith, Alan B. Northrup
-
Publication number: 20160060255Abstract: The invention provides certain thiazole-substituted aminoheteroaryl compounds of the Formula (I) or pharmaceutically acceptable salts thereof, wherein X1, X2, X3, X4, Y1, Y2, Y3, Y4, and R4 are as defined herein. The invention also provides pharmaceutical compositions comprising such compounds, and methods of using the compounds for treating diseases or conditions mediated by Spleen Tyrosine Kinase (Syk).Type: ApplicationFiled: April 22, 2014Publication date: March 3, 2016Applicants: Merck Canada Inc., Merck Sharp & Dohme Corp.Inventors: Neville J. Anthony, Brian M. Andresen, Alan B. Northrup, Kaleen K. Childers, Anthony Donofrio, Thomas A. Miller, Yuan Liu, Michelle R. Machacek, Hyun Chong Woo, Kerrie B. Spencer, John Michael Ellis, Michael D. Altman, Eric T. Romeo, Daniel Guay, Jonathan Grimm, Marie-Eve Lebrun, Joel S. Robichaud, Liping Wang, Byron DuBois, Qiaolin Deng
-
Publication number: 20160031935Abstract: A compound of Formula (I): or a pharmaceutically acceptable salt, hydrate, solvate, or racemic mixture or stereoisomer thereof, and methods for preventing or treating an LDL-cholesterol-related disease or disorder using such compound(s), and kits and compositions comprising such compound(s).Type: ApplicationFiled: March 14, 2014Publication date: February 4, 2016Inventors: DANIEL GUAY, SHELDON CRANE, NICOLAS LACHANCE, JEAN-FRANCOIS CHIASSON, VOUY LINH TRUONG, PATRICK LACOMBE, KATHRYN SKOREY, NABIL G. SEIDAH
-
Patent number: 9242984Abstract: The present invention provides novel pyrazole derivatives of formula I which are potent inhibitors of spleen tyrosine kinase, and are useful in the treatment and prevention of diseases mediated by said enzyme, such as asthma, COPD, rheumatoid arthritis, and cancer.Type: GrantFiled: June 18, 2013Date of Patent: January 26, 2016Assignees: Merck Sharp & Dohme Corp., Merck Canada Inc.Inventors: Michelle R. Machacek, Michael D. Altman, Eric T. Romeo, Dilrukshi Vitharana, Brandon Cash, Tony Siu, Hua Zhou, Matthew Christopher, Solomon D. Kattar, Andrew M. Haidle, Kaleen Konrad Childers, Matthew L. Maddess, Michael H. Reutershan, Yves Ducharme, David J. Guerin, Kerrie Spencer, Christian Beaulieu, Vouy Linh Truong, Daniel Guay, Alan B. Northrup, Brandon M. Taoka, Jongwon Lim, Christian Fischer, John W. Butcher, Ryan D. Otte, Binyuan Sun, John Michael Ellis
-
Publication number: 20150239866Abstract: Provided are triazole derivatives of Formula I which are potent inhibitors of spleen tyrosine kinase and pharmaceutical composition. The triazole derivatives are useful in the treatment and prevention of diseases mediated by said enzyme, such as asthma, COPD, rheumatoid arthritis, and cancer.Type: ApplicationFiled: September 24, 2013Publication date: August 27, 2015Applicants: MERCK CANADA INC., MERCK SHARP & DOHME CORP.Inventors: Michelle R. MACHACEK, Eric T. ROMEO, Solomon D. KATTAR, Matthew CHRISTOPHER, Michael D. ALTMAN, Alan B. NORTHRUP, John Michael ELLIS, Brendan O BOYLE, Anthony DONOFRIO, Jonathan GRIMM, Michael H. REUTERSHAN, Kaleen Konrad CHILDERS, Ryan D. OTTE, Brandon CASH, Yves DUCHARME, Andrew M. HAIDLE, Kerrie SPENCER, Dilrukshi VITHARANA, Lingyun WU, Li ZHANG, Peng ZHANG, Christian BEAULIEU, Daniel GUAY
-
Publication number: 20150232428Abstract: The invention provides certain substituted phenyl compounds of the Formula (I) or pharmaceutically acceptable salts thereof, wherein R1, R2, R3, R4, Rcy, and t are as defined herein. The invention also provides pharmaceutical compositions comprising such compounds, and methods of using the compounds for treating diseases or conditions mediated by Spleen Tyrosine Kinase (Syk).Type: ApplicationFiled: August 15, 2013Publication date: August 20, 2015Applicants: Merck Canada Inc., Merck Sharp & Dohme Corp.Inventors: Andrew M. Haidle, Jason Burch, Daniel Guay, Jacques Yves Gauthier, Joel Robichaud, Jean Francois Fournier, John Michael Ellis, Matthew Christopher, Solomon D. Kattar, Graham F. Smith, Alan B. Northrup
-
Patent number: 9108843Abstract: A method for preparation of highly porous and preferentially-oriented {100} platinum on a substrate by electrodeposition in a deposition bath, comprising using a deposition potential Edep lower than ERHE+150 mV and an acidified platinum salt solution having a Pt salt concentration less than 5.0 mmole L?1 or, in presence of hydrogen, comprising limiting the concentration of Pt salts in the electrolyte to less than 5.0 mmole L?1 and controlling the temperature of the electrolyte. Preferentially-oriented {100} platinum nanowires and thin films, comprising Pt{100} in a range between about 20 and about 60% and having a roughness factor of at least 50 are produced.Type: GrantFiled: March 15, 2012Date of Patent: August 18, 2015Assignee: INSTITUT NATIONAL DE LA RECHERCHE SCIENTIFIQUEInventors: Erwan Bertin, Sébastien Garbarino, Daniel Guay, Manuel Martin, Alexandre Ponrouch
-
Publication number: 20150191461Abstract: The present invention provides novel pyrazole derivatives of formula I which are potent inhibitors of spleen tyrosine kinase, and are useful in the treatment and prevention of diseases mediated by said enzyme, such as asthma, COPD, rheumatoid arthritis, and cancer.Type: ApplicationFiled: June 18, 2013Publication date: July 9, 2015Applicant: Merck Sharp & Dohme Corp.Inventors: Michelle R. Machacek, Michael D. Altman, Eric T. Romeo, Dilrukshi Vitharana, Brandon Cash, Tony Siu, Matthew Christopher, Solomon D. Kattar, Andrew M. Haidle, Kaleen Konrad Childers, Matthew L. Maddess, Michael H. Reutershan, Yves Ducharme, David J. Guerin, Kerrie Spencer, Christian Beaulieu, Vouy Linh Truong, Daniel Guay, Alan B. Northrup, Brandon M. Taoka, Jongwon Lim, Christian Fischer, John W. Butcher, Ryan D. Otte, Binyuan Sun, John Michael Ellis
-
Publication number: 20150057316Abstract: The present description relates to compounds of Formula I (A+ X?), a diastereoisomer, an enantiomer, or a mixture thereof, pharmaceutical composition comprising same and uses thereof for gastrointestinal endoscopic and medical imaging applications, and for the treatment of visceral pain: Where R1 and R2 are as defined hereinType: ApplicationFiled: March 11, 2013Publication date: February 26, 2015Inventors: Jean-Francois Meunier, Cheuk Kun Lau, Daniel Guay, Gregory Bydlinski, Nadejda Spassova, Louis-David Cantin, Maxime Ranger
-
Publication number: 20140318952Abstract: An inert anode for Al electrolysis, made of Cu—Ni—Fe—O based materials, comprising Fe in a range between about 10 and 20% by weight, Cu in a range between about 60 and about 80% by weight, Ni in a range between about 20 and about 30% by weight, and oxygen in a range between about 1 and about 3% by weight, and a method for producing the anode, comprising mechanically alloying metallic elements; oxygen doping; and consolidation.Type: ApplicationFiled: September 27, 2012Publication date: October 30, 2014Inventors: Sebastien Helle, Daniel Guay, Lionel Roue
-
Publication number: 20140243290Abstract: The present invention provides novel pyrimidine amines of formula (I) which are potent inhibitors of spleen tyrosine kinase, and are useful in the treatment and prevention of diseases mediated by said enzyme, such as asthma, COPD and rheumatoid arthritis.Type: ApplicationFiled: April 17, 2014Publication date: August 28, 2014Inventors: Michael D. Altman, Brian M. Andresen, Kenneth L. Arrington, Sathesh Bhat, Jason Burch, Kaleen Konrad Childers, Bernard Cote, Maria Emilia Di Francesco, Anthony Donofrio, Kristina Dupont-Gaudet, John Michael Ellis, Christian Fischer, Jean-Francois Fournier, Jacques Yves Gauthier, Jonathan Grimm, Daniel Guay, David Joseph Guerin, Andrew M. Haidle, Solomon D. Kattar, Sandra Lee Knowles, Chaomin Li, Jongwon Lim, Michelle R. Machacek, Matthew L. Maddess, Alan B. Northrup, Brendan M. O'Boyle, Ryan D. Otte, Alessia Petrocchi, Michael H. Reutershan, Joel S. Robichaud, Eric T. Romeo, Adam J. Schell, Tony Siu, Kerrie B. Spencer, Brandon M. Taoka, B. Wesley Trotter, Hyun Chong Woo, Hua Zhou
-
Patent number: 8551984Abstract: The present invention provides novel pyrimidine amines of formula (I) which are potent inhibitors of spleen tyrosine kinase, and are useful in the treatment and prevention of diseases mediated by said enzyme, such as asthma, COPD and rheumatoid arthritis.Type: GrantFiled: December 15, 2010Date of Patent: October 8, 2013Assignees: Merck Sharp & Dohme Corp., Merck Canada Inc.Inventors: Michael D. Altman, Brian M. Andresen, Kenneth L. Arrington, Jason Burch, Kaleen Konrad Childers, Bernard Cote, Maria Emilia Di Francesco, Anthony Donofrio, Kristina Dupont-Gaudet, John Michael Ellis, Christian Fischer, Daniel Guay, David Joseph Guerin, Andrew M. Haidle, Solomon Kattar, Sandra Lee Knowles, Chaomin Li, Jongwon Lim, Michelle R. Machacek, Alan B. Northrup, Brendan M. O'Boyle, Ryan D. Otte, Michael H. Reutershan, Eric Romeo, Adam J. Schell, Tony Siu, Kerrie B. Spencer, Brandon M. Taoka, B. Wesley Trotter, Hua Zhou
-
Patent number: 8470410Abstract: A method for producing nanostructured coatings on a substrate, comprising: preparing a nanocrystalline powder of a powder size comprised between 1 and 60 ?m; and combining cleaning the surface of the substrate and cold spraying the nanocrystalline powder on the surface of the substrate, and a system for producing nanocrystalline coatings on a substrate, comprising a spray head, a cleaning head and a handling system monitoring the spray head and the cleaning head relative to the substrate to be coated, the spray head being a first cold spray head, the first cold spray head depositing on the substrate at least one nanocrystalline powder, the cleaning head optimizing the surface being coated with the at least one layer of nanocrystalline powder.Type: GrantFiled: December 21, 2010Date of Patent: June 25, 2013Assignees: Institut National de la Recherche Scientifique (INRS), National Research Council CanadaInventors: Daniel Guay, Éric Irissou, Jean Gabriel Legoux, Lionel Roué